GlucotrackGCTK
13F holders, Q3 2025 (September 30)8holders −2
1new positions
3sold out
$6.59avg. 13F price*
At the end of Q3 2025, 8 institutions reported holding Glucotrack Inc. (GCTK) in their 13F filings, down 2 from Q2 2025. 1 opened new positions and 3 sold out. The largest holders were Alerus Financial NA ($33K), Tower Research Capital LLC (TRC) ($5K) and Morgan Stanley ($3K).
- Company
- Glucotrack Inc.
- CUSIP
- 45824Q804
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $33K |
| Exits | 3 | $5K |
All 13F filers, Q2 2025 → Q3 2025: 5,439 shares bought and 5,822 shares sold, net −383 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Alerus Financial NA | 0.00% | New | 5,000 | $33K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -54.5% | 806 | $5K |
| Morgan Stanley | 0.00% | Add +40000.0% | 401 | $3K |
| UBS Group AG | 0.00% | Add +3900.0% | 40 | $263 |
| NFSG Corp | 0.00% | No change | 34 | $224 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -10.0% | 9 | $59 |
| Bank of America Corp. | 0.00% | Reduce -99.8% | 7 | $46 |
| Osaic Holdings, Inc. | 0.00% | No change | 1 | $7 |
"% of holder's portfolio" is GCTK's weight in each manager's 13F, not the share of Glucotrack Inc. the manager owns.